Format

Send to

Choose Destination
See comment in PubMed Commons below
Diabetes Technol Ther. 2013 Aug;15(8):609-18. doi: 10.1089/dia.2013.0177. Epub 2013 Aug 8.

An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology.

Author information

1
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

Abstract

A recent autopsy analysis asserted that incretin drugs have the potential of increasing the risk for pancreatic cancer and for pancreatic neuroendocrine tumors. We examined the Network for Pancreatic Organ Donors with Diabetes (nPOD) database from which that analysis was derived. Our findings raise important questions about the comparability of the two groups of diabetes patients used for the analysis. Our review of the data available on the nPOD Web site and our reading of the earlier article lead us to the conclusion that the data, and the implications of the data, as expressed by the authors of the autopsy analysis are vastly overstated and are a misrepresentation of the information available.

PMID:
23927624
DOI:
10.1089/dia.2013.0177
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Support Center